Multiple RT-PCR markers for the detection of circulating tumour cells of metastatic canine mammary tumours

Veterinary Journal

Volumn 196, Issue 1, 2013, Pages 34-39

  da Costa, A ^a   Kohn, B ^a   Gruber, A D ^a   Klopfleisch, R ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Canine mammary tumour; Circulating tumour cells; CRYAB; Dog; Metastasis

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE CLASS 1 TYPE 8B MEMBER 1; ALPHA CRYSTALLIN; CLAUDIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER 3; MESSENGER RNA; THROMBOPLASTIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD SAMPLING; BREAST CARCINOMA; CANCER PROGNOSIS; CIRCULATING TUMOR CELL; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; METASTASIS POTENTIAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY;

ADENOMA; ALPHA-CRYSTALLIN B CHAIN; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOGS; FEMALE; GENETIC MARKERS; HUMANS; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, ANIMAL; NEOPLASTIC CELLS, CIRCULATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

CANIDAE; CANIS FAMILIARIS;

EID: 84875582529     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.08.021     Document Type: Article

References (43)

1. Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao C., Tibbe A.G.J., Uhr J.W., Terstappen L.W.M.M. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research 2004, 10:6897-6904.
2. Alunni-Fabbroni M., Sandri M.T. Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods 2010, 50:289-297.
3. Attard G., de Bono J.S. Utilizing circulating tumor cells: Challenges and pitfalls. Current Opinion in Genetics and Development 2011, 21:50-58.
4. Bau D., Chang W., Lee M., Li F., Tsai C. Association of alpha B-Crystallin genotypes with oral cancer susceptibility, survival, and recurrence in Taiwan. European Journal of Cancer 2012, 48:S1-S5.
5. Bednarz-Knoll N., Alix-Panabieres C., Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Research 2011, 13:228.
6. Cao W.G., Yang W.P., Li H., Lou G.Y., Jiang J.S., Geng M., Xi W.Q., Ren R.B., Qu Q., Jin X.L., Zhu Y.B., Jin Y.N. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer. Journal of Surgical Oncology 2011, 103:110-115.
7. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer 2002, 2:563-572.
8. Cohen S.J., Punt C.J.A., Iannotti N., Saidman B.H., Sabbath K.D., Gabrail N.Y., Picus J., Morse M., Mitchell E., Miller M.C., Doyle G.V., Tissing H., Terstappen L.W.M.M., Meropol N.J. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Journal of Clinical Oncology 2008, 26:3213-3221.
9. Criscitiello C., Sotiriou C., Ignatiadis M. Circulating tumor cells and emerging blood biomarkers in breast cancer. Current Opinion in Oncology 2010, 22:552-558.
10. Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Seminars in Oncology 2006, 33:S9-14.
11. da Costa A.B., Kohn B., Oliveira J., Gartner E., Gruber A.D., Klopfleisch R. Genetic markers for the detection of circulating tumour cells in dogs with metastatic mammary tumours. Journal of Comparative Pathology 2010, 143:314.
12. da Costa A., Oliveira J.T., Gartner F., Kohn B., Gruber A.D., Klopfleisch R. Potential markers for detection of circulating canine mammary tumor cells in the peripheral blood. The Veterinary Journal 2011, 190:165-168.
13. de Albuquerque A., Kubisch I., Breier G., Stamminger G., Fersis N., Eichler A., Kaul S., Stolzel U. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: A feasibility study. Oncology 2012, 82:3-10.
14. de Bono J.S., Scher H.I., Montgomery R.B., Parker C., Miller M.C., Tissing H., Doyle G.V., Terstappen L.W., Pienta K.J., Raghavan D. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Journal of Urology 2009, 181:2535-2536.
15. Guvenc T., Gulbahar M.Y., Yarim M., Kabak Y.B., Karayigit O., Sozmen M. Alpha basic crystallin expression in canine mammary tumors. Journal of Veterinary Science 2012, 13:39-42.
16. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M.R., Hayes D.F., Bast R.C. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of Clinical Oncology 2007, 25:5287-5312.
17. Hayes D.F., Walker T.M., Singh B., Vitetta E.S., Uhr J.W., Gross S., Rao C., Doyle G.V., Terstappen L.W. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. International Journal of Oncology 2002, 21:1111-1117.
18. Hayes D.F., Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Miller M.C., Matera J., Allard W.J., Doyle G.V., Terstappen L.W. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clinical Cancer Research 2006, 12:4218-4224.
19. Jiang W.G., Martin T.A., Mansel R.E. Molecular detection of micro-metastasis in breast cancer. Critical Reviews in Oncology and Hematology 2002, 43:13-31.
20. Khoja L., Backen A., Sloane R., Menasce L., Ryder D., Krebs M., Board R., Clack G., Hughes A., Blackhall F., Valle J.W., Dive C. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. British Journal of Cancer 2012, 106:508-516.
21. Klopfleisch R., Gruber A.D. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. Journal of Comparative Pathology 2009, 141:113-120.
22. Klopfleisch R., Gruber A.D. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas. Veterinary Pathology 2009, 46:416-422.
23. Klopfleisch R., Klose P., Weise C., Bondzio A., Multhaup G., Einspanier R., Gruber A.D. Proteome of metastatic canine mammary carcinomas: Similarities to and differences from human breast cancer. Journal of Proteome Research 2010, 9:6380-6391.
24. Klopfleisch R., Lenze D., Hummel M., Gruber A.D. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer 2010, 10:618.
25. Klopfleisch R., Lenze D., Hummel M., Gruber A.D. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas. The Veterinary Journal 2011, 190:236-243.
26. Klopfleisch R., Sperling C., Kershaw O., Gruber A.D. Does the taking of biopsies affect the metastatic potential of tumours? A systematic review of reports on veterinary and human cases and animal models. The Veterinary Journal 2011, 190:e31-42.
27. Klopfleisch R., von Euler H., Sarli G., Pinho S.S., Gartner F., Gruber A.D. Molecular carcinogenesis of canine mammary tumors: News from an old disease. Veterinary Pathology 2011, 48:98-116.
28. Klose P., Weise C., Bondzio A., Multhaup G., Einspanier R., Gruber A.D., Klopfleisch R. Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?. Journal of Proteome Research 2011, 10:4405-4415.
29. Krebs M.G., Hou J.M., Sloane R., Lancashire L., Priest L., Nonaka D., Ward T.H., Backen A., Clack G., Hughes A., Ranson M., Blackhall F.H., Dive C. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. Journal of Thoracic Oncology 2012, 7:306-315.
30. Laganowsky A., Benesch J.L.P., Landau M., Ding L.L., Sawaya M.R., Cascio D., Huang Q.L., Robinson C.V., Horwitz J., Eisenberg D. Crystal structures of truncated alphaA and alphaB crystallins reveal structural mechanisms of polydispersity important for eye lens function. Protein Science 2010, 19:1031-1043.
31. Meng S.D., Tripathy D., Frenkel E.P., Shete S., Naftalis E.Z., Huth J.F., Beitsch P.D., Leitch M., Hoover S., Euhus D., Haley B., Morrison L., Fleming T.P., Herlyn D., Terstappen L.W.M.M., Fehm T., Tucker T.F., Lane N., Wang J.Q., Uhr J.W. Circulating tumor cells in patients with breast cancer dormancy. Clinical Cancer Research 2004, 10:8152-8162.
32. Molnar B., Floro L., Sipos F., Toth B., Sreter L., Tulassay Z. Elevation in peripheral blood circulating tumor cell number correlates with macroscopic progression in UICC stage IV colorectal cancer patients. Disease Markers 2008, 24:141-150.
33. Mostert B., Sleijfer S., Foekens J.A., Gratama J.W. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer. Cancer Treatment Reviews 2009, 35:463-474.
34. Naito T., Tanaka F., Ono A., Yoneda K., Takahashi T., Murakami H., Nakamura Y., Tsuya A., Kenmotsu H., Shukuya T., Kaira K., Koh Y., Endo M., Hasegawa S., Yamamoto N. Prognostic impact of circulating tumor cells in patients with small cell lung cancer. Journal of Thoracic Oncology 2012, 7:512-519.
35. Nieva J., Wendel M., Luttgen M.S., Marrinucci D., Bazhenova L., Kolatkar A., Santala R., Whittenberger B., Burke J., Torrey M., Bethel K., Kuhn P. High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis. Physical Biology 2012, 9.
36. Ou K., Yu K., Kesuma D., Hooi M., Huang N., Chen W., Lee S.Y., Goh X.P., Tan L.K., Liu J., Soon S.Y., Rashid S.B.A., Putti T.C., Jikuya H., Ichikawa T., Nishimura O., Salto-Tellez M., Tan P. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. Journal of Proteome Research 2008, 7:1518-1528.
37. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nature Reviews Cancer 2004, 4:448-456.
38. Poveda A., Kaye S.B., McCormack R., Wang S.B., Parekh T., Ricci D., Lebedinsky C.A., Tercero J.C., Zintl P., Monk B.J. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer. Gynecologic Oncology 2011, 122:567-572.
39. Saad F., Pantel K. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. Future Oncology 2012, 8:321-331.
40. Schuster R., Bechrakis N.E., Stroux A., Busse A., Schmittel A., Thiel E., Foerster M.H., Keilholz U. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma. Oncology 2011, 80:57-62.
41. Seitz S., Korsching E., Weimer J., Jacobsen A., Arnold N., Meindl A., Arnold W., Gustavus D., Klebig C., Petersen I., Scherneck S. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression. Genes, Chromosomes and Cancer 2006, 45:612-627.
42. Sleeman J.P., Nazarenko I., Thiele W. Do all roads lead to Rome? Routes to metastasis development. International Journal of Cancer 2011, 128:2511-2526.
43. Weigelt B., Bosma A.J., Hart A.A.M., Rodenhuis S., van't Veer L.J. Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients. British Journal of Cancer 2003, 88:1091-1094.